Papilledema: Clinical Trials

2 trials for Papilledema, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow Papilledema: new trials by email Literature Review of Papilledema trials Research Report on Papilledema

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Injected Ranibizumab to Treat Macular Telangiectasia With New Blood Vessel Formation
Ranibizumab - Telangiectasia
Phase 1CompletedNational Eye Institute (NEI)52007-03-272017-07-02
Injected Ranibizumab to Treat Macular Telangiectasia Without New Blood Vessel Formation
Ranibizumab - Telangiectasia
Phase 1CompletedNational Eye Institute (NEI)52007-03-272017-07-02

Narrower conditions

Idiopathic Juxtafoveal Retinal Telangiectasia (2)  ·  Telangiectasis (2)

Broader conditions

Cardiovascular Diseases (2)  ·  Cranial Nerve Diseases (2)  ·  Eye Diseases (2)  ·  Nervous System Diseases (2)  ·  Optic Nerve Diseases (2)  ·  Vascular Diseases (2)

Interventions

Ranibizumab (2)

Sponsors

National Eye Institute (NEI) (2)

Countries

United States (2)